EG238829 Inhibitors
EG238829 inhibitors are a class of chemical compounds that specifically target and block the activity of the molecular entity **EG238829**, which may be involved in key biochemical pathways such as enzymatic reactions, signal transduction, or molecular transport. While the exact function of EG238829 may vary, inhibitors of this molecule are designed to interfere with its normal biological role, allowing researchers to investigate the impact of its inhibition on various cellular processes. These inhibitors work by binding to EG238829 or its active site, thereby preventing it from interacting with other molecules or executing its function within the cell. This inhibition can provide insight into the precise biochemical or structural role EG238829 plays in maintaining cellular processes, such as energy metabolism, molecular signaling, or protein regulation.
The study of EG238829 inhibitors is important for understanding how this molecule integrates into broader molecular networks and contributes to cellular homeostasis. By inhibiting EG238829, researchers can observe changes in related biochemical pathways, uncovering its potential interactions with other proteins, enzymes, or cellular structures. These studies also provide valuable information on how EG238829's activity regulates key cellular functions, such as protein synthesis, metabolic cycles, or cell signaling pathways. Furthermore, by analyzing the effects of EG238829 inhibition, scientists can gain insights into the regulatory mechanisms that control its activity and how these mechanisms adapt when its function is blocked. This research contributes to a deeper understanding of the molecular dynamics that drive cellular processes and the role of specific inhibitors in elucidating the importance of key proteins like EG238829.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine inhibits protein kinases, including PKC, impacting various cellular functions. It may indirectly influence Cldn34b3 by modulating downstream signaling pathways linked to tight junction assembly and cell adhesion, potentially disrupting its predicted functions in tight junctions and the plasma membrane. | ||||||
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $20.00 $62.00 $116.00 $246.00 $799.00 | 23 | |
EGTA chelates calcium ions, potentially disrupting calcium-dependent cellular processes. Cldn34b3, involved in bicellular tight junction assembly, might be indirectly impacted by EGTA through interference with calcium-dependent signaling pathways critical for tight junction formation and maintenance. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632 inhibits Rho-associated protein kinases (ROCK), influencing cytoskeletal dynamics. It may indirectly affect Cldn34b3 by modulating ROCK-mediated pathways, potentially altering the cytoskeletal organization critical for tight junction assembly and cell adhesion. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $28.00 $37.00 | 18 | |
Indomethacin inhibits cyclooxygenases, affecting prostaglandin synthesis. Its impact on inflammatory pathways may indirectly influence Cldn34b3, potentially altering signaling cascades related to cell adhesion and tight junction assembly in response to inflammatory stimuli. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is a PI3K inhibitor, impacting the PI3K/Akt signaling pathway. Cldn34b3, active in the plasma membrane, may be indirectly inhibited by Wortmannin through interference with PI3K signaling, potentially affecting cellular processes linked to tight junction assembly and cell adhesion. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Latrunculin A disrupts actin dynamics by sequestering monomeric actin. It may indirectly impact Cldn34b3 by altering actin cytoskeleton organization, influencing cellular processes associated with bicellular tight junction assembly and cell adhesion. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
KN-93 inhibits CaMKII, affecting calcium-dependent signaling. It may indirectly influence Cldn34b3 by modulating CaMKII-mediated pathways, potentially disrupting tight junction assembly and cell adhesion processes that rely on calcium-dependent signaling. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB-431542 inhibits the TGF-β receptor, impacting TGF-β signaling. Cldn34b3, involved in cell adhesion, may be indirectly inhibited by SB-431542 through interference with TGF-β signaling, potentially affecting cellular processes associated with tight junction assembly and adhesion. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $180.00 $299.00 | 59 | |
Jasplakinolide stabilizes F-actin, impacting actin cytoskeleton dynamics. It may indirectly influence Cldn34b3 by modulating actin organization, potentially disrupting cellular processes associated with bicellular tight junction assembly and cell adhesion. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
2-APB inhibits IP3 receptors and TRP channels, impacting calcium signaling. It may indirectly affect Cldn34b3 by modulating calcium-dependent pathways critical for tight junction assembly and cell adhesion, potentially disrupting the predicted functions of Cldn34b3 in the plasma membrane. | ||||||